Adaptive Biotechnologies Corporation
US ˙ NasdaqGS ˙ US00650F1093

SecurityADPT / Adaptive Biotechnologies Corporation
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in ADPT / Adaptive Biotechnologies Corporation

On November 12, 2025 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Adaptive Biotechnologies Corporation (US:ADPT) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 887 shares of Adaptive Biotechnologies Corporation. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (ADPT) in the form of stock options. The firm currently holds call options representing 6,900 of underlying shares valued at $112,056 USD and put options representing 1,700 of underlying shares valued at $27,608 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ADPT / Adaptive Biotechnologies Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-12 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -887 -100.00 0 -100.00
2025-08-14 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 887 887 10 0.0000
2025-05-14 2024-12-31 13F/A-1 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -1,619 -100.00 0 -100.00
2025-02-14 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -1,619 0
2024-11-14 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,619 1,619 8 0.0000
2024-08-14 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -3,462 -100.00 0 -100.00
2024-05-10 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 3,462 -27,396 -88.78 11 -92.72 0.0000
2024-02-14 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 30,858 13,873 81.68 151 64.13 0.0004
2023-11-09 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 16,985 14,648 626.79 93 513.33 0.0003
2023-08-09 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 2,337 -2,141 -47.81 16 -61.54 0.0001
2023-05-12 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 4,478 -34,311 -88.46 40 -86.82 0.0001
2023-02-09 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 38,789 38,789 296 0.0007
2022-11-09 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -3,428 -100.00 0 -100.00
2022-08-11 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 3,428 -13,340 -79.56 28 -87.98 0.0000
2022-05-12 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 16,768 16,768 233 0.0002
2021-11-12 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -810 -100.00 0 -100.00
2021-08-10 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 810 -921 -53.21 33 -52.86 0.0000
2021-05-12 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,731 1,731 70 0.0001
2020-05-12 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -1,478 -100.00 0 -100.00
2020-02-10 2019-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,478 1,478 44 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 6,900 -48.12 112 -43.43 n/a n/a n/a
2025-11-12 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 13,300 232.50 199 330.43 n/a n/a n/a
2025-08-14 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 4,000 122.22 47 253.85 n/a n/a n/a
2025-05-14 2025-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 1,800 -80.65 13 -76.36 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ADAPTIVE BIOTECHNOLOGIES COR COM Call 9,300 3.33 56 19.57 n/a n/a n/a
2025-02-14 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 9,300 56 n/a n/a n/a
2024-11-14 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 9,000 -43.75 46 -19.30 n/a n/a n/a
2024-08-14 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 16,000 1,500.00 58 1,800.00 n/a n/a n/a
2024-05-10 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 1,000 -96.97 3 -98.14 n/a n/a n/a
2024-02-14 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 33,000 -17.50 162 -26.15 n/a n/a n/a
2023-11-09 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 40,000 3,233.33 218 2,625.00 n/a n/a n/a
2023-08-09 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 1,200 -96.94 8 -97.69 n/a n/a n/a
2023-05-12 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 39,200 39,100.00 346 n/a n/a n/a
2023-02-09 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 100 -98.15 1 -100.00 n/a n/a n/a
2022-11-09 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 5,400 1,250.00 38 1,166.67 n/a n/a n/a
2022-08-11 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 400 300.00 3 200.00 n/a n/a n/a
2022-05-12 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 100 -98.08 1 -99.32 n/a n/a n/a
2022-02-11 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 5,200 205.88 146 151.72 n/a n/a n/a
2021-11-12 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 1,700 -89.44 58 -91.19 n/a n/a n/a
2021-08-10 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 16,100 906.25 658 928.13 n/a n/a n/a
2021-05-12 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 1,600 -92.69 64 -95.06 n/a n/a n/a
2021-02-10 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 21,900 -65.78 1,295 -58.39 n/a n/a n/a
2020-11-12 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 64,000 48.15 3,112 48.90 n/a n/a n/a
2020-08-13 2020-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 43,200 195.89 2,090 414.78 n/a n/a n/a
2020-05-13 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 14,600 274.36 406 247.01 n/a n/a n/a
2020-02-10 2019-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 3,900 254.55 117 244.12 n/a n/a n/a
2019-11-12 2019-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Call 1,100 34 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 1,700 0.00 28 8.00 n/a n/a n/a
2025-11-12 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 1,700 112.50 25 177.78 n/a n/a n/a
2025-08-14 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 800 9 n/a n/a n/a
2024-08-14 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-10 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 4,300 -90.29 14 -94.01 n/a n/a n/a
2024-02-14 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 44,300 10.75 217 -0.46 n/a n/a n/a
2023-11-09 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 40,000 218 n/a n/a n/a
2023-08-09 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-12 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 15,000 47.06 132 71.43 n/a n/a n/a
2023-02-09 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 10,200 78 n/a n/a n/a
2022-11-09 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-11 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 1,600 -90.24 13 -94.30 n/a n/a n/a
2022-05-12 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 16,400 16,300.00 228 7,500.00 n/a n/a n/a
2022-02-11 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 100 -66.67 3 -70.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 300 -97.03 10 -97.58 n/a n/a n/a
2021-08-10 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 10,100 119.57 413 123.24 n/a n/a n/a
2021-05-12 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 4,600 4,500.00 185 2,983.33 n/a n/a n/a
2021-02-10 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 100 -85.71 6 -82.35 n/a n/a n/a
2020-11-12 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 700 -92.39 34 -92.36 n/a n/a n/a
2020-08-13 2020-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 9,200 607.69 445 1,136.11 n/a n/a n/a
2020-05-13 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 1,300 36 n/a n/a n/a
2020-02-10 2019-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-12 2019-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM Put 100 3 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.